The New SARS-CoV-2 Variants and Their Epidemiological Impact in Mexico

The COVID-19 disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus started its deadly journey into a global pandemic in Wuhan, China, in December 2019, where it was first isolated. Subsequently, multiple variants of the virus have been identified worldwide. In this...

Full description

Saved in:
Bibliographic Details
Published in:mBio 2022-10, Vol.13 (5), p.e0106021-e0106021
Main Authors: García-López, Rodrigo, Laresgoiti-Servitje, Estibalitz, Lemus-Martin, Roselyn, Sanchez-Flores, Alejandro, Sanders-Velez, Carlos
Format: Article
Language:English
Subjects:
COVID-19 pandemic
genomic vigilance
Minireview
SARS-CoV-2 variants
vaccination
Virology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The COVID-19 disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus started its deadly journey into a global pandemic in Wuhan, China, in December 2019, where it was first isolated. Subsequently, multiple variants of the virus have been identified worldwide. In this review, we discuss the overall landscape of the pandemic in Mexico, including its most prevalent variants, their surveillance at a genomic level, and how they impacted the epidemiology of the disease. We also evaluate the heterologous vaccination in Mexico and how it may have influenced group immunity and helped mitigate the pandemic. Finally, we present an integrated view that could help us to understand the pandemic and serve as an example of the situation in Latin America.
ISSN:2150-7511
2150-7511
DOI:10.1128/mbio.01060-21